Phase 1 Trial Investigating the Safety and Tolerability of Leflunomide in Patients with Steroid-Dependent Chronic Graft-Versus-Host Disease (cGVHD) after Allogeneic Hematopoietic Cell Transplant (alloHCT)

Authors
Category Primary study
JournalTransplantation and Cellular Therapy
Year 2024
This article has no abstract
Epistemonikos ID: f67d0ce8087147da9f36f9e5c4a3a0448471cf45
First added on: Feb 17, 2025